Tapewire

Nasdaq · USD

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Export transactions ↓
Tapewire entity
4419
SEC CIK
0001801170
Parsed reports
342

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202602
Feb 202600
Mar 202602
Apr 202600
May 202603
Jun 202605
Jul 2026010
Aug 202602
Sep 202606
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2025 Filed Mar 18, 2025 20:53 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 6,354 $3.66 $23,255.64
Disclosure

SEC source: 0001801170-25-000073 · wk-form4_1742331202.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,270,134

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 20:53 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 9,188 $3.66 $33,628.08
Disclosure

SEC source: 0001801170-25-000073 · wk-form4_1742331202.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,276,488

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 20:51 UTC
Wai ConradCEO, Counterpart Health
Tax withholdingClass A Common Stock 80,524 $3.66 $294,717.84
Disclosure

SEC source: 0001801170-25-000072 · wk-form4_1742331058.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,263,539

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:12 UTC SaleClass A Common Stock 200,000 $3.61 $722,000.00
Disclosure

SEC source: 0001801170-25-000068 · wk-form4_1741723964.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,227

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.54 to $3.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 23:11 UTC
Priest Brady PatrickCEO of Home Care
SaleClass A Common Stock 75,000 $3.68 $276,000.00
Disclosure

SEC source: 0001801170-25-000066 · wk-form4_1741389106.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,418,151

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.68 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 22:59 UTC
Soares KarenGeneral Counsel & Secretary
SaleClass A Common Stock 52,500 $3.80 $199,500.00
Disclosure

SEC source: 0001801170-25-000064 · wk-form4_1741388350.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299,663

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:49 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 5,345 $4.46 $23,838.70
Disclosure

SEC source: 0001801170-25-000043 · wk-form4_1740001752.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,352,163

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
February 08, 2025 Filed Feb 11, 2025 21:19 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 85,535 $4.32 $369,511.20
Disclosure

SEC source: 0001801170-25-000041 · wk-form4_1739308770.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,263,482

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:19 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 28,553 $4.39 $125,347.67
Disclosure

SEC source: 0001801170-25-000039 · wk-form4_1738703965.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,357,508

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:18 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 21,578 $4.39 $94,727.42
Disclosure

SEC source: 0001801170-25-000038 · wk-form4_1738703923.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,285,676

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:15 UTC
Wai ConradCEO, Counterpart Health
Tax withholdingClass A Common Stock 24,470 $4.39 $107,423.30
Disclosure

SEC source: 0001801170-25-000036 · wk-form4_1738703750.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,344,063

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 21:16 UTC
Priest Brady PatrickCEO of Home Care
Tax withholdingClass A Common Stock 18,987 $4.39 $83,352.93
Disclosure

SEC source: 0001801170-25-000037 · wk-form4_1738703792.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,493,151

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 18, 2025 Filed Jan 22, 2025 22:04 UTC
Priest Brady PatrickCEO of Home Care
Tax withholdingClass A Common Stock 38,560 $4.08 $157,324.80
Disclosure

SEC source: 0001801170-25-000031 · wk-form4_1737583467.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,512,138

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 18, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:34 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionClass B Common Stock · Derivative 1,670,965 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · derivative · entry 5

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,904,343

Underlying: Class A Common Stock · 1,670,965 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:34 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionClass B Common Stock · Derivative 3,342,698 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · derivative · entry 4

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,575,308

Underlying: Class A Common Stock · 3,342,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:34 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionRestricted Stock Unit · Derivative 3,342,698 Not disclosed Not disclosed
Disclosure

SEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · derivative · entry 3

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,342,699

Underlying: Class B Common Stock · 3,342,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.underlying: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:34 UTC
Garipalli VivekDirector · 10% owner
Tax withholdingClass A Common Stock 1,670,965 $3.60 $6,015,474.00
Disclosure

SEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · nonDerivative · entry 2

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,409,267

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:34 UTC
Garipalli VivekDirector · 10% owner
Exercise / conversionClass A Common Stock 1,670,965 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · nonDerivative · entry 1

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,080,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:11 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 4,308 $3.60 $15,508.80
Disclosure

SEC source: 0001801170-25-000025 · wk-form4_1736543473.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,386,061

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of the final 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on June 15, 2021.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:10 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 17,142 $3.60 $61,711.20
Disclosure

SEC source: 0001801170-25-000024 · wk-form4_1736543420.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,307,254

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2025, due to the vesting of the final 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 16:41 UTC GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000017 · wk-form4_1736372458.xml · nonDerivative · entry 1

Tran Thomas L · CIK 0001403759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,664

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 16:33 UTC
SHAPIRO LEEDirector
GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000015 · wk-form4_1736371994.xml · nonDerivative · entry 1

SHAPIRO LEE · CIK 0001213350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 598,622

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 21:30 UTC GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000013 · wk-form4_1736371799.xml · nonDerivative · entry 1

Clinton Chelsea · CIK 0001530920 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 602,814

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 16:44 UTC GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000018 · wk-form4_1736372634.xml · nonDerivative · entry 1

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 518,622

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 21:50 UTC GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000019 · wk-form4_1736373009.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 473,227

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 21:39 UTC GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000016 · wk-form4_1736372385.xml · nonDerivative · entry 1

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 599,816

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.

F2 · balance_after: The Reporting Person no longer has a reportable indirect beneficial interest in the following shares: (i) 20,000 shares of the Issuer's Class A Common Stock previously acquired by the Reporting Person and held by her now ex-spouse's IRA; and (ii) 1300 and 1500 shares of the Issuer's Class A Common Stock held by her Son's and Daughter's custodial accounts, respectively, and previously acquired by the Reporting Person. Each such holding was included in the Reporting Person's prior ownership report.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 21:28 UTC GrantClass A Common Stock 60,975 $0.00 $0.00
Disclosure

SEC source: 0001801170-25-000012 · wk-form4_1736371725.xml · nonDerivative · entry 1

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 526,615

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 21:12 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 8,149 $3.29 $26,810.21
Disclosure

SEC source: 0001801170-25-000005 · wk-form4_1736284350.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,324,396

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 21:20 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 278,765 $3.15 $878,109.75
Disclosure

SEC source: 0001801170-25-000003 · wk-form4_1735939220.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,349,017

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 21:18 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 6,391 $3.11 $19,876.01
Disclosure

SEC source: 0001801170-24-000251 · wk-form4_1734470327.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,390,369

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 21:17 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 8,691 $3.11 $27,029.01
Disclosure

SEC source: 0001801170-24-000248 · wk-form4_1734470222.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,332,545

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 21:17 UTC
Wai ConradCEO, Counterpart Health
Tax withholdingClass A Common Stock 98,217 $3.11 $305,454.87
Disclosure

SEC source: 0001801170-24-000249 · wk-form4_1734470256.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,368,533

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 21:17 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 12,567 $3.11 $39,083.37
Disclosure

SEC source: 0001801170-24-000248 · wk-form4_1734470222.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,341,236

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:11 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 7,444 $3.08 $22,927.52
Disclosure

SEC source: 0001801170-24-000238 · wk-form4_1731964288.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,396,760

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 21:23 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 85,367 $3.41 $291,101.47
Disclosure

SEC source: 0001801170-24-000236 · wk-form4_1731446592.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,627,782

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 23:37 UTC
Soares KarenGeneral Counsel & Secretary
Tax withholdingClass A Common Stock 152,040 $4.12 $626,404.80
Disclosure

SEC source: 0001801170-24-000229 · wk-form4_1730763421.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,404,204

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 22:47 UTC
Wai ConradCEO, Counterpart Health
Tax withholdingClass A Common Stock 111,496 $4.12 $459,363.52
Disclosure

SEC source: 0001801170-24-000228 · wk-form4_1730760424.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,466,750

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 22:44 UTC
Priest Brady PatrickCEO of Home Care
Tax withholdingClass A Common Stock 100,320 $4.12 $413,318.40
Disclosure

SEC source: 0001801170-24-000227 · wk-form4_1730760240.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,550,698

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 22:40 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 118,050 $4.12 $486,366.00
Disclosure

SEC source: 0001801170-24-000225 · wk-form4_1730760036.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,353,803

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:07 UTC
Priest Brady PatrickCEO of Home Care
Tax withholdingClass A Common Stock 48,305 $4.00 $193,220.00
Disclosure

SEC source: 0001801170-24-000217 · wk-form4_1729627629.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,651,018

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 18, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:17 UTC
Soares KarenGeneral Counsel & Secretary
GrantClass A Common Stock 450,955 $0.00 $0.00
Disclosure

SEC source: 0001801170-24-000215 · wk-form4_1729196226.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,556,244

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:17 UTC
Reynoso Jamie L.CEO, Medicare Advantage
GrantClass A Common Stock 726,114 $0.00 $0.00
Disclosure

SEC source: 0001801170-24-000214 · wk-form4_1729196216.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,471,853

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:16 UTC
Priest Brady PatrickCEO of Home Care
GrantClass A Common Stock 726,114 $0.00 $0.00
Disclosure

SEC source: 0001801170-24-000213 · wk-form4_1729196206.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,699,323

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:16 UTC
Wai ConradCEO, Counterpart Health
GrantClass A Common Stock 726,114 $0.00 $0.00
Disclosure

SEC source: 0001801170-24-000212 · wk-form4_1729196197.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,578,246

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 20:16 UTC
Toy AndrewDirector · Chief Executive Officer
GrantClass A Common Stock 1,910,828 $0.00 $0.00
Disclosure

SEC source: 0001801170-24-000211 · wk-form4_1729196186.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,713,149

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 20:39 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 8,706 $4.00 $34,824.00
Disclosure

SEC source: 0001801170-24-000200 · wk-form4_1728333576.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,745,739

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 21:08 UTC
Toy AndrewDirector · Chief Executive Officer
Tax withholdingClass A Common Stock 308,341 $2.78 $857,187.98
Disclosure

SEC source: 0001801170-24-000197 · wk-form4_1727903310.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,802,321

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 1, 2024, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 20:07 UTC
Soares KarenGeneral Counsel & Secretary
Disposition to issuerClass A Common Stock 6,391 $2.99 $19,109.09
Disclosure

SEC source: 0001801170-24-000191 · wk-form4_1726603636.xml · nonDerivative · entry 3

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,105,289

F3 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 15, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 20:06 UTC
Reynoso Jamie L.CEO, Medicare Advantage
Tax withholdingClass A Common Stock 8,691 $2.99 $25,986.09
Disclosure

SEC source: 0001801170-24-000190 · wk-form4_1726603594.xml · nonDerivative · entry 4

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,754,445

F4 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document
September 14, 2024 Filed Sep 17, 2024 20:07 UTC
Wai ConradChief Technology Officer
Tax withholdingClass A Common Stock 98,217 $2.99 $293,668.83
Disclosure

SEC source: 0001801170-24-000192 · wk-form4_1726603663.xml · nonDerivative · entry 3

Wai Conrad · CIK 0001971702 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,852,132

F3 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.